Skip to main content
Equibles
LUNG logo

LUNG · Pulmonx Corp · Metrics

Track LUNG — free

Use LUNG with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LUNG.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.95 -0.01 (-0.26%) Earnings today
Rebalance outlook locked
Market Cap
$83.75M
Shares
42.95M
Volume · Oct 27 45.33K Avg daily vol (3M) 492.6K

LUNG metrics

92 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.95
Market cap
$83.75M

Price action

20 metrics
Price change (1W)
+11.4%
Price change (30D)
-0.5%
Price change (3M)
+59.8%
Price change (6M)
+52.3%
Price change (YTD)
-11.8%
Price change (1Y)
+18.9%
Trailing year
Price change (5Y)
-95.1%
52-week high
$2.60
52-week low
$1.17
Change from 52-week high
-25.0%
Change from 52-week low
+66.7%
Annualized volatility
95.6%
Annualized volatility (3M)
104.1%
Beta
2.0
RSI (14D)
54.7
Price vs SMA 50
-3.5%
Price vs SMA 200
+18.7%
Avg volume (3M)
492,595
Relative volume
1.3
Average dollar volume
$973,399

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
42.95M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
0.7×
reciprocal yield 145.1%
EV / EBITDA
—
EV / EBIT
—
P / sales
0.9×
reciprocal yield 111.3%
P / book
2.0
reciprocal yield 49.9%
FCF yield
-39.0%
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
—
Earnings yield
-61.2%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.7×
reciprocal yield 37.0%
EV / revenue historical average (5Y)
7.2×
reciprocal yield 13.8%
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
0.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
2026-10-27
Last earnings
2026-07-29

Profitability

9 metrics
Gross margin
77.1%
Operating margin
-53.0%
Trailing 12 months
Net margin
-55.0%
Gross profit (TTM)
$67.38M
Operating profit (TTM)
−$46.31M
Net income (TTM)
−$48.12M
Trailing 12 months
Diluted EPS (TTM)
$-1.16
FCF margin
-35.1%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$2.10
Gross profit per diluted share (TTM)
$1.62
Operating profit per diluted share (TTM)
$-1.11
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
$-1.16
Operating cash flow per diluted share (TTM)
$-0.73
Free cash flow per diluted share (TTM)
$-0.74
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
$0.46
Stock compensation per diluted share (TTM)
$0.41
Book value per share
$1.30

Growth

11 metrics
Revenue growth YoY
-4.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$87.44M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+5.0%
Year over year · more shares
Revenue CAGR (3Y)
+19.0%
Revenue CAGR (5Y)
+22.6%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-122.8%
Return on assets
-41.9%
Debt / equity
1.0
Current ratio
4.3
EBITDA (TTM)
—
Free cash flow (TTM)
−$30.67M
Quick ratio
3.5
Interest coverage
-12.3
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$18.31M
Latest balance sheet
Cash & equivalents
$55.84M
Total assets
$114.73M
Total debt
$37.53M

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$30.56M
Capital expenditures (TTM)
$112,000
R&D (TTM)
$19.36M
SG&A (TTM)
$94.33M
Stock compensation (TTM)
$17.24M
R&D / revenue
22.1%
Stock compensation / revenue
19.7%

Ownership (13F)

9 metrics
13F filers
107
13F filer change QoQ
-7
Institutional ownership
62.1%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
29.9%
Private-fund adviser ownership
19.0%
Active holders' share change QoQ
-5.9%
Holder tenure
11.8
Price vs estimated holder cost
-90.1%

Ownership (registered funds)

1 metrics
Index-fund ownership
7.0%

Short interest

3 metrics
Short interest
1.6%
Latest settlement · 2.5 days to cover
Days to cover
2.5d
Short-squeeze score
58 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$177,048
Insider-sentiment score
23 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1127537 CUSIP 745848101 13F (30d) 9 filings 9 filers Visit website Investor relations